Risk management following international standards in the routine of an umbilical cord blood bank
DOI:
https://doi.org/10.33448/rsd-v11i8.30265Keywords:
Blood bank; Quality management; Risk analysis; Healthcare failure mode and effect analysis; Stem cells.Abstract
This work demonstrates the main elements of the risk management system at a Brazilian umbilical cord blood bank, taking into account the criticality and individuality of the procedures as well as regulatory and certifying agency guidelines. This study involved the implementation of a Risk Management Committee which was responsible for process flow mapping; identifying, analyzing, classifying, treating, and monitoring risks using brainstorming, flowcharts, Pareto distribution, Ishikawa diagrams, and FMEA. Almost 900 risks were divided into 16 sectors, with 24% of total risks in the Blood Processing sector, demonstrating a strong relationship between critical activities and exposure to risks. Occurrence and severity were defined, followed by risk treatment and monitoring. The risk management system provided a more reliable infrastructure to customers and employees, upgraded the capabilities of the company, successful ISO 9001: 2015 certification, and renew American Association of Blood Bank accreditation. This paper presents a specific look at the implementation of a risk management system in a private umbilical cord blood bank. Typically, this sort of information is kept in internal company documents and is not widely disclosed in the literature. In this sense, this study presents a useful perspective for practitioners and academics.
References
AABB Accredited Cord Blood (CB) Facilities. (n.d.). Accredited cord blood facilities. https://www.aabb.org/standards-accreditation/accreditation/accredited-facilities/cell-therapy-services/aabb-accredited-cord-blood-facilities.
Alcorta, N., & Enrique, P. (2017). Risk management in blood bank processes: quality applied in prevention of events. Hematology & Transfusion International Journal, 5, 240–243.10.15406/htij.2017.05.00119
American Association of Blood Banks. (2017). Standards for Cellular Therapy Services. Bethesda, MD, The United States of America: AABB.
Bambi, F., Spitaleri, I., Verdolini, G., Gianassi, S., Perri, A., Dori, F., & Iadanza, E. (2009). Analysis and management of the risks related to the collection, processing and distribution of peripheral blood haematopoietic stem cells. Blood Transfusion, 7, 3–17. 10.2450/2008.0006-08
Brazil, Agência Nacional de Vigilância Sanitária (ANVISA). (2018). Resolução da Diretoria Colegiada (RDC) 214 de 07/02/2018. https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2018/rdc0214_07_02_2018.pdf.
Brazil, Agência Nacional de Vigilância Sanitária (ANVISA). (2003). Resolução da Diretoria Colegiada (RDC) 190 de 18/07/2003. https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2003/rdc0190_18_07_2003.html.
Broxmeyer, H. E., Lee, M.-R., Hangoc, G., Cooper, S., Prasain, N., Kim, Y.-J., Mallett, C., Ye, Z., Witting, S., Cornetta, K., Cheng, L., & Yoder, M. C. (2011). Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood, 117, 4773–4777. doi:10.1182/blood-2011-01-330514
Deming, W. E. (2000). Out of the crisis. Cambridge, MA, The United States of America: MIT Press.
de Moraes, A. S., de Souza, C. R. R. M., Lima, C. B. O, Silva, I. G., Souza, J. S., Santos, J. A. S., Silva, L. R., dos Santos, L. S., Santana, M. F., Maranhão, M. V., Vale, N. S., & Lordêlo, I. C. L. S. (2022). Células tronco em terapias hematológicas: uma revisão de literatura. Research, Society and Development, 11, e32511729073. 10.33448/rsd-v11i7.29073
Food and Drug Administration. (2019). Guidance for Industry - BLA for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bla-minimally-manipulated-unrelated-allogeneic-placentalumbilical-cord-blood-intended-hematopoietic.
Gluckman, E., Broxmeyer, H. E., Auerbach, A. D., Friedman, H. S., Douglas, G. W., Devergie, A., Esperou, H., Thierry, D., Socie, G., Lehn, P., Cooper, S., English, D., Kurtzberg, J., Bard, J., & Boyse, E.A. (1989). Hematopoietic Reconstitution in a Patient with Fanconi’s Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling. New England Journal of Medicine, 321, 1174–1178. 10.1056/NEJM198910263211707
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). (2005). Q9 Quality Risk Management. https://database.ich.org/sites/default/files/Q9%20Guideline.pdf.
ISO. (2018). ISO 31000:2018 - Risk management - Guidelines. Geneva, Switzerland: ISO.
ISO. (2015). ISO 9001:2015 - Quality management systems - Requirements. Geneva, Switzerland: ISO.
Lopez, F., Di Bartolo, C., Piazza, T., Passannanti, A., Gerlach, Jc., Gridelli, B., & Triolo, F. (2010). A quality risk management model approach for cell therapy manufacturing. Risk analysis : an official publication of the Society for Risk Analysis, 30(12), 1857-71. 10.1111/j.1539-6924.2010.01465.x
Najafpour, Z., Hasoumi, M., Behzadi, F., Mohamadi, E., Jafary, M., & Saeedi, M. (2017). Preventing blood transfusion failures: FMEA, an effective assessment method. BMC Health Services Research, 17, Article number: 453. 10.1186/s12913-017-2380-3
Pandey, D., Kaur, S., & Kamath, A. (2016). Banking Umbilical Cord Blood (UCB) Stem Cells: Awareness, Attitude and Expectations of Potential Donors from One of the Largest Potential Repository (India). PLoS One, 11(5):e0155782. 10.1371/journal.pone.0155782
Risso, M. A., Luzo, Â. C. M., Mendes-Takao, M. R., Romagnolo, A. G., Bovolato, A. L. de C., Silva, P. L. da, Deffune, E., & on behalf of the BrazilCord Network. (2018). Umbilical Cord Blood Collection, Storage, and Use: A Brazilian Experience. Stem Cells Translational Medicine, 7(Suppl 1): S21. 10.1002/sctm.12372
Stamatis, D. H. (2003). Failure Mode and Effect Analysis: FMEA from Theory to Execution. Milwaukee, WI, The United States of America: ASQ Quality Press.
Tague, N. R. (2005). The Quality Toolbox. Milwaukee, WI, The United States of America: ASQ Quality Press.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Bianca Soares da Silva Marques; Silvia Leticia Ferreira de Oliveira Cunha; Luana dos Santos Guimarães; Janaina José dos Santos Machado; Luis Eduardo da Cruz; Flávia Almada do Carmo; Luiz Cláudio Rodrigues Pereira da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
